米国市場銘柄情報

FEMY フェマシス

銘柄追加

1.2700
-0.0600-4.51%

終値 04/26 16:00 ET

1.2600
-0.0100-0.79%

市場後 19:52 ET

2,806.62万時価総額-1365直近PER

フェマシスに関するコメント

ログインコメントを投稿

sinothegoat

04/12 22:32

$フェマシス(FEMY.US)$ attempting to break its support line at 1.39ish, lets see if it stays strong or if it breaks and enters a free fall. if it stays above this mark, we could see an upwards correction all the way to 1.8-2

101879331

03/26 21:05

$フェマシス(FEMY.US)$ any idea?

Trytosaveabit

03/20 20:27

GAP up rule now in affect for me!

$フェマシス(FEMY.US)$ Will wait untill i see buy side increase but lower is the way i see it today? Hope im wrong?

Trytosaveabit

03/20 20:19

News

$フェマシス(FEMY.US)$ Femasys Announces Topline Data From Pivotal Trial For FemaSeed For Treatment Of Infertility; Says In The Severe Male Factor Cohort, Findings Show 24% Of Women Became Pregnant After FemaSeed, FemaSeed Pregnancy Rate By Cycle Was More Than Double Historic Intrauterine Insemination Rate

Trytosaveabit

03/06 22:05

Update

$フェマシス(FEMY.US)$ Femasys Completes First In-Office Commercial Procedure With FemaSeed Infertility Solution

Sturgeons and Stocks

03/05 09:34

$シャオペン(XPEV.US)$$フェマシス(FEMY.US)$$ニューヨーク・コミュニティー・バンコープ(NYCB.US)$$Digital World Acquisition Corp(DWAC.US)$

10% Gaps DWAC XEPEV PLTR NYCB TSLL FEMY

From YouTube

Stock Region

02/29 08:18

Biomedical Company Announces Clearance From FDA For Infertility Treatment

Femasys' FemaSeed: A Groundbreaking FDA-Cleared Alternative to IVF for Infertility Treatment.
In a significant development that could transform the fertility treatment landscape, Femasys Inc. (NASDAQ:FEMY), a biomedical company, has announced that their product, FemaSeed, has received clearance from the Food and Drug Administration (FDA). This marks the first localized directional insemination product for women experiencing...